The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York of the Federal Food, Drug, and Cosmetic Act (FDCA).* FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law